U.S. District Court Rules Against Merck & Co., Inc. in TEMODAR(R) (temozolomide) Patent Lawsuit With TEVA Pharmaceuticals USA

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck & Co., Inc. announced today that the U.S. District Court for the District of Delaware ruled against the company in a patent infringement suit against Teva Pharmaceuticals USA Inc.